LifeStance Health Group Inc

For the period ended Dec 31, 2023. Filed Feb 28, 2024.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Feb 28, 2024

LFST$14.60+6.0%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Signatures

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.

	LifeStance Health Group, Inc.
Date: February 28, 2024	By:	/s/ Kenneth Burdick
		Kenneth Burdick
		Chief Executive Officer

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this Report has been signed below by the following persons on behalf of the Registrant in the capacities and on the dates indicated.

Robert Bessler
Name	Title	Date
/s/ Kenneth Burdick	Chief Executive Officer and Chairman	February 28, 2024
Kenneth Burdick	(Principal Executive Officer)
/s/ David Bourdon	Chief Financial Officer and Treasurer	February 28, 2024
David Bourdon	(Principal Financial and Accounting Officer)
/s/ Robert Bessler	Director	February 28, 2024
/s/ Darren Black	Director	February 28, 2024
Darren Black
/s/ Jeffrey Crisan	Director	February 28, 2024
Jeffrey Crisan
/s/ William Miller	Director	February 28, 2024
William Miller
/s/ Jeffrey Rhodes	Director	February 28, 2024
Jeffrey Rhodes
/s/ Eric Shuey	Director	February 28, 2024
Eric Shuey
/s/ Seema Verma	Director	February 28, 2024
Seema Verma
/s/ Katherine Wood	Director	February 28, 2024
Katherine Wood

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.